Physician

George P Skopis, MD

According to 2025 Medicare claims, George Skopis, MD (NPI: 1306362181) practices ophthalmology in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Sarasota, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 34232-6282.

Skopis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 627 traditional Medicare patients, billed 21,971 HCPCS/CPT codes, and received $1,281,456 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 602 prescription claims across 174 beneficiaries totaling $22,002 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 22 records totaling $741. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,579 and ending at $22,002. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$641K$1.3M2022 Medicare payment: $8,055 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $309,076 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,281,456 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20223487$8,055
20232904,428$309,076
202462721,971$1,281,456

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$31K2018 Drug cost: $10,579 (USD; Tot_Drug_Cst)2019 Drug cost: $21,715 (USD; Tot_Drug_Cst)2020 Drug cost: $24,517 (USD; Tot_Drug_Cst)2021 Drug cost: $31,032 (USD; Tot_Drug_Cst)2022 Drug cost: $9,977 (USD; Tot_Drug_Cst)2023 Drug cost: $14,756 (USD; Tot_Drug_Cst)2024 Drug cost: $22,002 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201851139$10,579
201968201$21,715
202071254$24,517
202179272$31,032
202257100$9,977
202390306$14,756
2024174602$22,002

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system253253$99
67028Injection of drug into eye251616$93
92012Established patient problem focused exam of visual system314503$65
92134Imaging of retina5491,100$29
92201Extended exam of the back part of the eye with retinal drawing235258$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1204,304$4,026
DifluprednateDifluprednate22657$2,527
Ketorolac TromethamineKetorolac Tromethamine441,000$1,070
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha851,875$918
Brimonidine TartrateBrimonidine Tartrate652,991$664

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$741Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for George P. Skopis, MD?

Tedicare shows public-source Medicare data for George P. Skopis, MD (NPI 1306362181), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George P. Skopis, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George P. Skopis, MD?

George P. Skopis, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does George P. Skopis, MD have Open Payments data?

George P. Skopis, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.